Patent · US Active

Poxviral oncolytic vectors

US9180150B2 · kind B2 · utility

16Cited by
3References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 2008
Grant dateNov 10, 2015
Priority date—
Expiry dateAug 24, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/24143
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A poxvirus comprising a defective F2L gene and compositions comprising such poxvirus are useful for therapeutic purposes, and more particularly for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.